Feng Qi

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (7) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Author Correction: Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (7) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)
Feng Qi, Jian Zhang, Jia Li, Donghe Li, Na Gao, Zhuoran Qi, Xiuyan Kong, Zhijie Yu, Yuan Fang, Wenguo Cu, Jinglin Xia
Synergistic immunochemotherapy targeted SAMD4B-APOA2-PD-L1 axis potentiates antitumor immunity in hepatocellular carcinoma. Cell death & disease 15 (6) (2024)